# A Study of GenSci098 in Subjects With Active Thyroid Eye Disease

> **NCT06569758** · PHASE1 · RECRUITING · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 76 (estimated)

## Conditions studied

- Safety
- Tolerability
- GenSci098
- Thyroid Eye Disease (TED)

## Interventions

- **DRUG:** GenSci098
- **DRUG:** GenSci098 Placebo

## Key facts

- **NCT ID:** NCT06569758
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-24
- **Primary completion:** 2027-09-02
- **Final completion:** 2027-12-13
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06569758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06569758, "A Study of GenSci098 in Subjects With Active Thyroid Eye Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06569758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*